Literature DB >> 3142815

The presence of a reduced amount of 32-kd "protective" protein is a distinct biochemical finding in late infantile galactosialidosis.

P Strisciuglio1, G Parenti, C Giudice, S Lijoi, A T Hoogeveen, A d'Azzo.   

Abstract

The biochemical defect underlying the late infantile form of galactosialidosis has been investigated in fibroblasts from two patients presenting with this phenotype. Immunoprecipitation experiments demonstrated that a reduced amount of 32-kd "protective" protein and a normal amount of its precursor are present in late infantile galactosialidosis fibroblasts, while neither of the two polypeptides are detectable in early infantile and juvenile/adult fibroblasts. Leupeptin treatment led to a slight increase in the amount of 54-kd and 32-kd polypeptides in both late-infantile galactosialidosis cell lines. Uptake studies in one of the two cell lines confirmed the hypothesis that a block in the maturation of the protective protein is responsible for the late infantile type of galactosialidosis. This mutation seems to be a distinct finding in all patients affected by this form of the disease.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3142815     DOI: 10.1007/bf01790104

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  12 in total

1.  GM1 gangliosidosis in skin fibroblast culture: enzymatic differences between types 1 and 2 and observations on a third variant.

Authors:  L Pinsky; J Miller; B Shanfield; G Watters; L S Wolfe
Journal:  Am J Hum Genet       Date:  1974-09       Impact factor: 11.025

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Biosynthesis of lysosomal enzymes in fibroblasts. Phosphorylation of mannose residues.

Authors:  A Hasilik; E F Neufeld
Journal:  J Biol Chem       Date:  1980-05-25       Impact factor: 5.157

4.  Atypical expression of beta-galactosidase deficiency in a child with Hurler-like features but without neurological abnormalities.

Authors:  G Andria; E Del Giudice; A J Reuser
Journal:  Clin Genet       Date:  1978-07       Impact factor: 4.438

5.  Synthesis and processing of alpha-galactosidase A in human fibroblasts. Evidence for different mutations in Fabry disease.

Authors:  P Lemansky; D F Bishop; R J Desnick; A Hasilik; K von Figura
Journal:  J Biol Chem       Date:  1987-02-15       Impact factor: 5.157

6.  Purification and partial characterization of lysosomal neuraminidase from human placenta.

Authors:  F W Verheijen; S Palmeri; H Galjaard
Journal:  Eur J Biochem       Date:  1987-01-02

7.  Complementation, cross correction, and drug correction studies of combined beta-galactosidase neuraminidase deficiency in human fibroblasts.

Authors:  P Strisciuglio; K E Creek; W S Sly
Journal:  Pediatr Res       Date:  1984-02       Impact factor: 3.756

8.  Faulty association of alpha- and beta-subunits in some forms of beta-hexosaminidase A deficiency.

Authors:  A d'Azzo; R L Proia; E H Kolodny; M M Kaback; E F Neufeld
Journal:  J Biol Chem       Date:  1984-09-10       Impact factor: 5.157

9.  The relation between human lysosomal beta-galactosidase and its protective protein.

Authors:  A T Hoogeveen; F W Verheijen; H Galjaard
Journal:  J Biol Chem       Date:  1983-10-25       Impact factor: 5.157

10.  Different mutations in Ashkenazi Jewish and non-Jewish French Canadians with Tay-Sachs disease.

Authors:  R Myerowitz; N D Hogikyan
Journal:  Science       Date:  1986-06-27       Impact factor: 47.728

View more
  5 in total

1.  Galactosialidosis: neuropathological findings in a case of the late-infantile type.

Authors:  K Oyanagi; E Ohama; K Miyashita; H Yoshino; T Miyatake; M Yamazaki; F Ikuta
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

2.  Conjunctival biopsy in adult form galactosialidosis.

Authors:  T Usui; S Sawaguchi; H Abe; K Iwata; K Oyanagi
Journal:  Br J Ophthalmol       Date:  1993-03       Impact factor: 4.638

3.  Characteristics of the beta-galactosidase-carboxypeptidase complex in GM1-gangliosidosis and beta-galactosialidosis fibroblasts.

Authors:  R M D'Agrosa; M Hubbes; S Zhang; R Shankaran; J W Callahan
Journal:  Biochem J       Date:  1992-08-01       Impact factor: 3.857

Review 4.  Genetic Factors of Cerebral Small Vessel Disease and Their Potential Clinical Outcome.

Authors:  Vo Van Giau; Eva Bagyinszky; Young Chul Youn; Seong Soo A An; Sang Yun Kim
Journal:  Int J Mol Sci       Date:  2019-09-03       Impact factor: 5.923

5.  A mutation in a mild form of galactosialidosis impairs dimerization of the protective protein and renders it unstable.

Authors:  X Y Zhou; N J Galjart; R Willemsen; N Gillemans; H Galjaard; A d'Azzo
Journal:  EMBO J       Date:  1991-12       Impact factor: 11.598

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.